ZEN-3694
ZEN-3694 is a BET bromodomain inhibitor that overcomes resistance to androgen signaling inhibitors. It is used in preclinical research, including in vitro and in vivo models, to study combination therapies for treatment-resistant prostate cancers such as metastatic castration-resistant prostate cancer.
Product Specifications
CAS Number
1643947-30-1
Product Name Alternative
ZEN 3694, ZEN3694, ZEN-3694, BET, EpigeneticReaderDomain, Epigenetic Reader Domain
Field of Research
Epigenetics & Chromatin
Purity
98.00% (May vary between batches)
Solubility
DMSO:45 mg/mL (134.98 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6 mM)
Smiles
C (N1C=2C (N=C1NC) =NC=C (C2) C=3C (C) =NOC3C) C4=CC=CC=C4
Molecular Formula
C19H19N5O
Molecular Weight
333.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Recombinant Neisseria meningitidis serogroup C/serotype 2a GMP synthase [glutamine-hydrolyzing] (guaA), partial](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
MBS1188189 Inquire
Recombinant Neisseria meningitidis serogroup C/serotype 2a GMP synthase [glutamine-hydrolyzing] (guaA), partial
Sign In for Pricing
View Details 